APA (7th ed.) Citation

G, C., M, V., A, F., S, L., E, C., C, C., . . . Investigators, 3. (2010). Evaluation of platelet inhibition by tirofiban in patients stratified according to aspirin and clopidogrel responsiveness: The 3T/2R (Tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel). Journal of the American College of Cardiology (JACC), 55(3), 255. https://doi.org/10.1016/j.jacc.2009.08.052

Chicago Style (17th ed.) Citation

G, Campo, Valgimigli M, Frangione A, Luccarelli S, Cangiano E, Cavazza C, Fileti L, Ferrari R, and 3T/2R Investigators. "Evaluation of Platelet Inhibition by Tirofiban in Patients Stratified According to Aspirin and Clopidogrel Responsiveness: The 3T/2R (Tailoring Treatment with Tirofiban in Patients Showing Resistance to Aspirin And/or Resistance to Clopidogrel)." Journal of the American College of Cardiology (JACC) 55, no. 3 (2010): 255. https://doi.org/10.1016/j.jacc.2009.08.052.

MLA (9th ed.) Citation

G, Campo, et al. "Evaluation of Platelet Inhibition by Tirofiban in Patients Stratified According to Aspirin and Clopidogrel Responsiveness: The 3T/2R (Tailoring Treatment with Tirofiban in Patients Showing Resistance to Aspirin And/or Resistance to Clopidogrel)." Journal of the American College of Cardiology (JACC), vol. 55, no. 3, 2010, p. 255, https://doi.org/10.1016/j.jacc.2009.08.052.